Bioinformatics approaches for the analysis of lipidomics data
Laxmana Rao Yetukuri
VTT
5
2010
PO-092 Inhibition of the mTORC1-pathway can feedback-activate H-RAS or K-RAS
IM Posada , B Lectez , F Siddiqui , C Oetken-Lindholm
ESMO Open 3
2018
Serum lipidomic profiling identifies biomarkers associated with progression to type 2 diabetes in the METSIM study
L Yetukuri , H Cederberg , M Sysi-Aho , T Hyotylainen
Diabetologia 56 S60 -S60
1
2013
Rasvasolujen solukalvo mukautuu ylimääräiseen rasvaan
Laxman Yetukuri , Sergio Rodriguez-Cuenca , Anna-Liisa Ruskeepää , Antonio Vidal-Puig
Duodecim 127 ( 14) 1493
2011
Informatics strategies for phenotype characterization using lipid pathways
Mikko Katajamaa , Laxman Yetukuri , Tuulikki Seppänen-Laakso , Gema Medina-Gomez
intelligent systems in molecular biology
2007
Regulation of lipid metabolism in breast cancer
Marko Sysi-Aho , Laxman Yetukuri , Mika Hilvo , Tuulikki Seppänen-Laakso
Metabolomics 2010: Breakthroughs in plant, microbial and human biology, clinical and nutritional research, and biomarker discovery
2010
Informatics and computational strategies for the study of lipids
Laxman Yetukuri , Kim Ekroos , Antonio Vidal-Puig , Matej Orešič
Molecular BioSystems 4 ( 2) 121 -127
170
2008
Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men
Tommi Suvitaival , Isabel Bondia-Pons , Laxman Yetukuri , Päivi Pöhö
Metabolism-clinical and Experimental 78 1 -12
53
2018
Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1
Otto Kauko , Susumu Y. Imanishi , Evgeny Kulesskiy , Laxman Yetukuri
Journal of Biological Chemistry 295 ( 13) 4194 -4211
38
2020
Genomic, Transcriptomic, and Lipidomic Profiling Highlights the Role of Inflammation in Individuals With Low High-density Lipoprotein Cholesterol
Pirkka-Pekka Laurila , Ida Surakka , Antti-Pekka Sarin , Laxman Yetukuri
Arteriosclerosis, Thrombosis, and Vascular Biology 33 ( 4) 847 -857
38
2013
High Density Lipoprotein Structural Changes and Drug Response in Lipidomic Profiles following the Long-Term Fenofibrate Therapy in the FIELD Substudy
Laxman Yetukuri , Ilkka Huopaniemi , Artturi Koivuniemi , Marianna Maranghi
PLoS ONE 6 ( 8) e23589 -12
44
2011
Algorithms and tools for the preprocessing of LC–MS metabolomics data
Sandra Castillo , Peddinti Gopalacharyulu , Laxman Yetukuri , Matej Orešič
Chemometrics and Intelligent Laboratory Systems 108 ( 1) 23 -32
199
2011
Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism--the GENOBIN study.
Ursula Schwab , Tuulikki Seppänen-Laakso , Laxman Yetukuri , Jyrki Ågren
PLOS ONE 3 ( 7)
73
2008
Association of Lipidome Remodeling in the Adipocyte Membrane with Acquired Obesity in Humans
Kirsi H. Pietiläinen , Tomasz Róg , Tuulikki Seppänen-Laakso , Sam Virtue
PLoS Biology 9 ( 6) e1000623
167
2011
Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity
Maria Kolak , Jukka Westerbacka , Vidya R. Velagapudi , Dick Wågsäter
Diabetes 56 ( 8) 1960 -1968
359
2007
Control of MYC-dependent apoptotic threshold by a co-amplified ubiquitin E3 ligase UBR5
Xi Qiao , Ying Liu , Maria Llamazares Prada , Abhishekh Gupta
bioRxiv 515247
2019
Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes.
Matej Orešič , Satu Simell , Marko Sysi-Aho , Kirsti Näntö-Salonen
Journal of Experimental Medicine 205 ( 13) 2975 -2984
331
2008
Gut microbiota affects lens and retinal lipid composition.
Matej Orešič , Tuulikki Seppänen-Laakso , Laxman Yetukuri , Fredrik Bäckhed
Experimental Eye Research 89 ( 5) 604 -607
27
2009
Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner.
Itziar M.D. Posada , Benoit Lectez , Mukund Sharma , Christina Oetken-Lindholm
Oncotarget 8 ( 27) 44550 -44566
19
2017
Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
Mika Hilvo , Carsten Denkert , Laura Lehtinen , Berit Müller
Cancer Research 71 ( 9) 3236 -3245
508
2011